跳轉至內容
Merck
全部照片(1)

重要文件

檢視所有文件

C-015

Supelco

可待因标准液 溶液

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C18H21NO3
CAS號碼:
76-57-3
分子量：:
299.36
EC號碼:
200-659-6
MDL號碼:
MFCD06764379
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

certified reference material

品質等級

300

形狀

liquid

特點

SNAP-N-SPIKE®, SNAP-N-SHOOT®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

濃度

100 μg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

形式

single component solution

儲存溫度

2-8°C

SMILES 字串

COc1ccc2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C

InChI

1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1

InChI 密鑰

OROGSEYTTFOCAN-DNJOTXNNSA-N

基因資訊

human ... OPRD1(4985) , OPRK1(4986) , OPRM1(4988)

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

可待因是一种具有镇痛、镇咳和镇静作用的阿片类药物，是鸦片中第二大主要生物碱。此认证参考溶液作为校准物或对照品中的起始材料，用于临床毒理学、法医分析、制药研究和止痛处方监测等的各种LC/MS或GC/MS检验方法。作为一种广泛流行的消遣性药物，可待因在澳大利亚、新西兰、罗马尼亚、瑞典和美国等国家受到了多种麻醉品管制法的监管。由于鸦片被归类为受控物质，Cerrilliant都是以免DEA溶液的形式提供绝大多数鸦片参考标准品的，这带来了更高的便利性。

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

產品號碼
描述
訂價

C-006

可待因标准液 溶液, 1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-053

6-乙酰可待因标准液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-005

可待因-D3 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-007

可待因-D3 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-040

可待因-D6 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-041

可待因-D6 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-071

13种疼痛管理混标 溶液, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

O-020

五种阿片类混标 溶液, 250 μg/mL each component in methanol, ampule of 1.0 mL, certified reference material, Cerilliant®

C-087

可待因-6- β-D-葡糖苷酸 溶液, 100 μg/mL in methanol: water (2:8), ampule of 1 mL, certified reference material, Cerilliant®

D-019

二氢可待因盐酸盐标准液 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

D-021

Dihydrocodeine-D6 hydrochloride solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

D-087

Dihydrocodeine-D6 hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-005

去甲可待因 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes,Central nervous system

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

49.5 °F - closed cup

閃點（°C）

9.7 °C - closed cup

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

K Krause et al.
Allergy, 68(2), 256-258 (2013-01-17)
Platelet-activating factor (PAF) causes wheal and flare responses which are abrogated by H1-antihistamines giving rise to the hypothesis that PAF-induced wheal development is secondary to histamine release from dermal mast cells. But is this hypothesis correct? Wheal and flare responses
Mladen V Tzvetkov et al.
Biochemical pharmacology, 86(5), 666-678 (2013-07-10)
We investigated whether morphine and its pro-drug codeine are substrates of the highly genetically polymorphic organic cation transporter OCT1 and whether OCT1 polymorphisms may affect morphine and codeine pharmacokinetics in humans. Morphine showed low transporter-independent membrane permeability (0.5 × 10⁻⁶
Rajeev Subramanyam et al.
International journal of pediatric otorhinolaryngology, 77(2), 194-199 (2012-11-20)
Although commonly performed, pediatric tonsillectomy is not necessarily a low risk procedure due to potentially life threatening perioperative complications. There is paucity of literature on lethal anesthesia and surgical complications of tonsillectomy. In this article, we have reviewed both minor
Codeine phosphate in paediatric medicine.
D G Williams et al.
British journal of anaesthesia, 86(3), 413-421 (2001-09-28)
Parvaz Madadi et al.
Pharmacogenomics, 9(9), 1267-1284 (2008-09-11)
Codeine has been used medicinally since the 1800s as an analgesic and antitussive agent. Although very few studies have methodically examined the safety of codeine use in the pediatric age group, it is nonetheless commonly prescribed to children and breastfeeding
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務